Nano-hplc-ms/ms

Show results for

Proteomics (2831)
Unknown (68)
Metabolomics (2)
Transcriptomics (1)

Organisms

Allexis (2786)
Homo sapiens (2786)
Mus musculus (2786)
Rattus norvegicus (2786)
Saccharomyces cerevisiae (2786)
Shigella (2786)
Shigella flexneri (2786)
Arabidopsis thaliana (2785)
Entamoeba histolytica HM-1:IMSS-A (2785)
Escherichia coli (2785)
Listeria monocytogenes (2785)
Schizosaccharomyces pombe (2785)
Solanum tuberosum (2785)
Staphylococcus aureus (2785)
Medicago truncatula (2784)
Sinorhizobium meliloti BL225C (2784)
Sus scrofa domesticus (2784)
Bos taurus (2783)
Callinectes sapidus (2783)
Leishmania major strain Friedlin (2783)
Homo sapiens (4)
Arabidopsis thaliana (1)
Mus musculus (1)
Aeromonas hydrophila subsp. hydrophila ATCC 7966 (1)
Bufo gargarizans gargarizans (1)
Bungarus sindanus (1)
Gallus gallus (1)
Streptococcus pneumoniae PT8114 (1)
Vibrio natriegens (1)
Saccharomyces cerevisiae (1)

Repository

pride (2787)
MassIVE (31)
iProX (6)
jPOST (5)
biostudies-arrayexpress (2)
MetaboLights (2)
NODE (1)

Tissue

Cell culture (587)
Epithelial cell (183)
Brain (129)
Permanent cell line cell (124)
Liver (88)
Blood plasma (76)
Blood (75)
Fibroblast (61)
Plant cell (57)
Cell suspension culture (52)
Leaf (50)
T cell (46)
Whole body (46)
Kidney (44)
Lung (42)
Colon (39)
Heart (38)
Blood cell (37)
Blood serum (35)
HeLa cell (35)
Primary cell (31)
Skin (30)
Hepatocyte (29)
Testis (29)
Macrophage (28)
Saliva (28)
B cell (27)
Root (27)
Bone marrow (25)
Cell line (1)

Disease

Disease free (79)
Colon cancer (55)
Breast cancer (53)
Acute leukemia (34)
Cervix carcinoma (18)
COVID-19 (16)
Malignant neoplasm of ovary (16)
Hepatocellular carcinoma (14)
Osteosarcoma (14)
Alzheimer's disease (13)
Glioblastoma (13)
Wounds and Injuries (13)
Cardiovascular system disease (12)
Plasmodium falciparum malaria (12)
Prostate adenocarcinoma (12)
Severe acute respiratory syndrome (12)
Parkinson's disease (11)
Type 2 diabetes mellitus (11)
Melanoma (10)
Lung cancer (8)
Lymphoma (8)
Multiple myeloma (8)
Non-small cell lung carcinoma (8)
Tuberculosis (8)
Brain cancer (7)
Brain glioblastoma multiforme (7)
Chronic myeloid leukemia (6)
Multiple sclerosis (6)
Obesity (6)
Pancreatic ductal adenocarcinoma (6)

Technology Type

Mass Spectrometry (2787)
Shotgun proteomics (1528)
Bottom-up proteomics (471)
Affinity purification coupled with mass spectrometry proteomics (349)
Data-dependent acquisition (260)
Gel-based experiment (230)
Data-independent acquisition (144)
Chemical cross-linking coupled with mass spectrometry proteomics (110)
Top-down proteomics (88)
SWATH MS (82)
SRM/MRM (40)
All-ion fragmentation (18)
Affinity proteomics (12)
DiaPASEF (10)
Mass spectrometry imaging (10)
MSE (5)
HDMSE (4)
Metaproteomics (4)
Proteogenomics (3)
Mass spectrometry (2)
Glycoproteomics (2)
Immunopeptidomics (2)
RNA mass spectrometry (1)

Instrument Platform

LTQ (5)
LTQ Orbitrap Elite (5)
Q Exactive (5)
LTQ Orbitrap Velos (3)
LTQ XL (2)
LTQ XL ETD (2)
Q Exactive HF (2)
LTQ Orbitrap Classic (Thermo Scientific) (2)
Impact (1)
LTQ Orbitrap (1)
LTQ Orbitrap Velos Pro (1)
Orbitrap Ascend (1)
Orbitrap Exploris 480 (1)
Orbitrap Fusion (1)
Q Exactive Plus (1)
Q Exactive plus (Thermo Scientific instrument model) (1)
TimsTOF Pro 2 (1)

Publication Date

2025 (365)
2023 (330)
2024 (326)
2022 (315)
2021 (298)
2026 (285)
2020 (253)
2019 (202)
2018 (146)
2017 (112)
2016 (97)
2015 (65)
2014 (24)
2013 (9)
2010 (1)
2009 (1)
2012 (1)

CHEBI ID

CHEBI:18272 (2)
CHEBI:27465 (2)
CHEBI:37713 (2)
CHEBI:17969 (2)
CHEBI:18199 (2)
CHEBI:16077 (2)
CHEBI:17052 (2)
CHEBI:17994 (2)
CHEBI:18319 (2)
CHEBI:18066 (2)
CHEBI:17013 (2)
CHEBI:15713 (2)
CHEBI:16264 (2)
CHEBI:17659 (2)
CHEBI:15721 (2)
CHEBI:48928 (2)
CHEBI:17050 (2)
CHEBI:16695 (2)
CHEBI:17533 (2)
CHEBI:52742 (2)
CHEBI:78682 (2)
CHEBI:15351 (2)
CHEBI:14314 (2)
CHEBI:15996 (2)
CHEBI:17552 (2)
CHEBI:15422 (2)
CHEBI:16027 (2)
CHEBI:16761 (2)
CHEBI:17345 (2)
CHEBI:80922 (1)

Metabolite Name

5'-phosphoribosyl-N-formylglycinamide (2)
5'-Thymidylic acid (2)
N-Acetyl-D-glucosamine 1,6-bisphosphate (2)
O-phospho-D-serine (2)
Shikimate-3-phosphate (2)
Sedoheptulose 1,7-bisphosphate (2)
Acetyl-CoA (2)
SAICAR (2)
5'-Guanylic acid (2)
Guanosine 5'-diphosphate (2)
UDP-N-acetylmuramoyl-L-alanyl-D-gamma-glutamyl-6-carboxy-L-lysyl-D-alanyl-D-alanine (2)
Uridine diphosphate glucose (2)
Ribose 1,5-bisphosphate (2)
Glucose-1-phosphate (2)
Uridine triphosphate (2)
Adenosine diphosphate (2)
Uridylic acid (2)
Adenosine 5'-monophosphate (2)
Sedoheptulose 7-phosphate (2)
Glucose-6 phosphate (2)
UDP-GlcNAc (2)
Adenosine triphosphate (2)
Guanosine triphosphate (2)
D-Fructose 1,6-bisphosphate (2)
N-Acetyl-L-glutamic acid (2)
Uridine 5'-diphosphate (2)
D-Ribose 5-phosphate (2)
6-phosphogluconic acid (2)
Uridine-5'-diphosphate-N-acetylmuramoyl-L-alanine (1)
Oxiglutatione (1)

Modification

4-tetrahydrothiazine-3-carboxylic acid (11)
4x(15)N labeled L-arginine (9)
2x(15)N labeled L-lysine (7)
15.994915 (6)
57.021464 (6)
-17.026549 (3)
42.010565 (3)
79.966331 (3)
-18.010565 (2)
N6-dimethyl-L-lysine (2)
Not available (2)
+3amu) (1)
0.984016 (1)
4 (1)
4-dinitrophenyl modified residue (1)
6x(2)H labeled dimethylated L-arginine (1)
N6 (1)

Study type

Proteomic profiling by mass spectrometer (1)
ChIP-chip by array (1)

Release Date

2019 (8)
2018 (7)
2010 (6)
2025 (6)
2024 (5)
2022 (5)
2023 (4)
2017 (4)
2013 (4)
2011 (4)
2009 (3)
2021 (3)
2020 (3)
2014 (3)
2016 (2)
2008 (2)
2012 (1)

Lab affiliation

Department of Biochemistry and Functional Proteomics, Institute of Biology II, Faculty of Biology and BIOSS Centre for Biological Signalling Studies, University of Freiburg, 79104 Freiburg im Breisgau, Germany (20)
University of Vienna, Faculty of Chemistry, Department of Analytical Chemistry (19)
Max Planck Institute for Terrestrial Microbiology Karl-von-Frisch Str. 10 35043 Marburg Germany (14)
Head Proteomics Group, Leiden University Medical Center, Center for Proteomics and Metabolomics, PO Box 9600, Postal zone P1-Q, 2300 RC Leiden, The Netherlands (11)
NCI/NIH CSB (10)
Centre for Proteome Research, University of Liverpool, Liverpool, UK (9)
Department of Convergence Medicine, Convergence Medicine Research Center/Biomedical Research Center, Asan Medical Center, Asan Institute for Life Sciences, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Republic of Korea. (8)
University of Warwick (8)
Department of Biomedical Sciences, University of Padova, Italy (7)
Evolutionary and translational venomics Lab, Instituto de Biomedicina de Valencia, CSIC (7)
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences (7)
Biozentrum, University of Basel, Switzerland (6)
Chair of Biochemistry II, Theodor Boveri-Institute, Biocenter, University of Würzburg, Würzburg, Germany (6)
Forschungszentrum Juelich ZEA-3 Analytics Wilhelm-Johnen-Str D-52425 Juelich Germany (6)
Universität Greifswald Institut für Pharmazie, AG Pharmazeutische Biotechnologie Greifswald, Germany (6)
Centre for Cancer Cell & Molecular Biology Barts Cancer Institute Queen Mary University of London Charterhouse Square London EC1M 6BQ U.K. (5)
Centre for Cancer Cell & Molecular Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK. (5)
Department of Biochemistry and Functional Proteomics, Institute of Biology II, Faculty of Biology and Signalling Research Centres BIOSS and CIBSS, University of Freiburg, 79104 Freiburg im Breisgau, Germany (5)
Head Proteomics Group, Leiden University Medical Center, Center for Proteomics and Metabolomics, PO Box 9600, Postal zone P1-Q, 2300 RC Leiden, The Netherlands (5)
Laboratory of Experimental Cancer Research, Department of Human Structure and Repair, Ghent University, Ghent, Belgium (5)
Proteomics Core Facility, Biozentrum, University of Basel, Switzerland (5)
University of Michigan (5)
University of Oxford (5)
1) Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, Switzerland 2) Faculty of Science, University of Zurich, Zurich, Switzerland (4)
Cornell University (4)
Department of Biochemistry, University of Oxford (4)
Functional Proteomics Lab, Faculty of Biology, University of Freiburg, Germany (4)
German Cancer Consortium (DKTK), partner site Freiburg German Cancer Research Center (DKFZ) Foundation under Public Law c/o Department of Urology Zentrale Klinische Forschung (ZKF) Medical Center-University of Freiburg Breisacher Str. 66, 79106 Freiburg, Germany (4)
Institute of Biochemistry II, Faculty of Medicine, Goethe University, Frankfurt, Germany (4)
King's College London (4)

Previous page
1 / 291
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 291
Next page

Sort by:

Relevance

Page size

Validation of MALDI-MS imaging data of selected membrane lipids in murine brain with and without laser postionization by quantitative nano-HPLC-MS using laser microdissection.

Not available

S-EPMC7496020 | biostudies-literature

mouse skeletal muscle nano-HPLC-MS/MS

differential proteomics regulated by ITGB6 in sakeletal muscle satellite cells

ORGANISM(S): Mus musculus (Mouse)

2022-08-12 | PXD028650 | Pride

Improved Sensitivity in Low-Input Proteomics using Micro-Pillar Array-based Chromatography

Capitalizing on the massive increase in sample concentrations which are produced by extremely low elution volumes, nano-LC-ESI-MS/MS is currently the most sensitive analytical technology for the comprehensive characterization of complex protein samples. However, despite tremendous technological impr...

ORGANISM(S): Homo sapiens (Human)

2019-10-23 | PXD014124 | Pride

Nano-lc-esi-ms/ms nano-flow hplc hela cell digest

Proteomic profile of Cephalosporin-Resistant Neisseria gonorrhoeae Isolates by low pH nano-HPLC-MS/MS

The experiment was performed using three N. gonorrhoeae clinical isolates and N. gonorrhoeae strain ATCC 49226 was used as a reference strain. Tandem mass spectra were processed by PEAKS Studio version 8.5 (Bioinformatics Solutions Inc., Waterloo, Canada). PEAKS DB was set up to search the database ...

ORGANISM(S): Neisseria gonorrhoeae

2019-10-22 | PXD015296 | Pride

Low ph nano-hplc-ms/ms cephalosporin-resistant neisseria gonorrhoeae

PneKC lanthipeptide Nano-HPLC-MS/MS

identification and characterization of class III antiviral lanthipeptide arrested at various stages of sequencial modification and maturation.

ORGANISM(S): Streptococcus Pneumoniae Pt8114

2024-08-13 | PXD047786 |

Msmeg overexpressing rv2577- protein identification in different cellular fractions

The presence of Rv2577 in the cell wall and soluble fractions was determined by nano-HPLC- MS/MS

ORGANISM(S): Mycobacterium smegmatis (strain ATCC 700084 / mc(2)155)

2021-09-09 | PXD019769 | Pride

Rv2577 Mycobacteria

Detection of plant protein in adulterated milk using nontargeted nano-high-performance liquid chromatography-tandem mass spectroscopy combined with principal component analysis.

Not available

S-EPMC6341172 | biostudies-literature

Nano HPLC Chip Ion Trap MS/MS of human pancreatic cancer cells

Proteins extracted from Panc1 cells (untreated or treated with ACPA or GW), were analyzed by 2-DE. Modulated proteins were identified by nanoHPLC Chip Ion trap. Bioinformatics pipeline: Mascot search was applied using the MS/MS ion search of Mascot against human entries of the non-redundant NCBI dat...

ORGANISM(S): Homo sapiens (Human)

2014-07-10 | PXD000119 | Pride

Human Lc ms/ms Panc1 cells

Nano-HPLC-MS/MS analysis for proteins encoded by circRNA in myoblasts and myotubes

The MS/MS spectra were searched against a custom protein database from span back-splice junction circRNA open reading frame prediction.

ORGANISM(S): Gallus Gallus

2020-08-21 | PXD021030 |

Chip-based nLC-TOF-MS is a highly stable technology for large-scale high-throughput analyses.

Not available

S-EPMC3640767 | biostudies-literature

Previous page
1 / 291
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 291
Next page

Sort by:

Relevance

Page size

2902 Results

Show results for

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

Modification

Study type

Release Date

Lab affiliation

OmicsDI is part of the ELIXIR infrastructure

Tweets